David Standaert, MD, PhD
Enriched profileJohn N. Whitaker Professor and Chair of Neurology · University of Alabama at Birmingham
David Standaert is John N. Whitaker Professor and Chair of Neurology at University of Alabama at Birmingham. OpenAlex indexes 441 publications with 33,043 citations (h-index 100); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David Standaert is John N. Whitaker Professor and Chair of Neurology at University of Alabama at Birmingham (Marnix E. Heersink School of Medicine, Department of Neurology). The public record shows 441 publications with 33,043 citations (h-index 100), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neuroscience and Neuropharmacology Research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 11 companies, 6 NIH-funded awards (2012–2022).
- Most recent indexed publication: 2026 · Brain
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 52 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 262.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Appointed to the inaugural federal Advisory Council on Parkinson's Research
Care, and Services (est. under the National Plan to End Parkinson's Act) …
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Sponsor: Michael J. Fox Foundation for Parkinson's Research
- Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
Sponsor: University of Alabama at Birmingham
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Industry payments
Updated 27 Aug 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20252 payments
- ABBVIE INC.Program year202510 payments
- Biogen, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine34.5%Clonazepam100%Part D≥13 patientsAromatic Amino Acid Decarboxylation Inhibitor26.6%Carbidopa-Levodopa68%Carbidopa-Levodopa-Entacapone32%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2012–2022 per NIH RePORTER. The latest:
- Innate and Adaptive Immunity in Parkinson Disease
University of Alabama at Birmingham
FY2022$1,873,001P50NS108675 - Project 1: Role of Innate Immune Cells in Human Parkinson Disease
University of Alabama at Birmingham
FY2022$419,913P50NS108675
Congress activity
Updated 27 Aug 2026
2 congress contributions (2020–2021) across ASTRO per OpenAlex. The most recent:
- Frameless MLC-Based Radiosurgical Thalamotomies on the Modern Linear Accelerator Platform ― Prospective Phase I/II Clinical Trial Results
ASTRO Annual Meeting
ASTRO2021Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01The Parkinson Progression Marker Initiative (PPMI)Article1,934 citations2011
- 02
- 03
- 04Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's DiseaseArticle706 citations2002
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-standaert-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Instagram
instagram.com/dgstandaert
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - ResearchGate
researchgate.net/scientific-contributions/David-G-Standaert-38407604
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/TheNewEnglandJournalofMedicine/videos/dr-david-standaert-chair-of-the-department-of-neurology-at-uab-the-university-of/420895797199899
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/reel/C5v3BnMBMql
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/posts/uab_recently-david-g-standaert-md-phd-activity-6993938344900472833-Xj42
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apdaparkinson.org ↗
- Board Certified
American Board of Psychiatry and Neurology (Neurology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Chair
Scientific Advisory Board, American Parkinson Disease Association (APDA), fourth chairman, board member since 2002
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apdaparkinson.org ↗ - Member
federal Advisory Council on Parkinson's Research, Care, and Services (established under the National Plan to End Parkinson's Act)
Awards & honors
honors on the public record- APDA George C. Cotzias
MD Fellowship recipient
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apdaparkinson.org ↗
Secondary affiliations
appointments beyond the home institution- Former faculty member
Harvard Medical School / Massachusetts General Hospital (1995-2006), where he directed the MGH/MIT Udall Center of Excellence in PD Research
2006verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗ - Director
Center for Neurodegeneration and Experimental Therapeutics, UAB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apdaparkinson.org ↗ - Director
Division of Movement Disorders, Department of Neurology, UAB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apdaparkinson.org ↗
Media & interviews
press, podcasts and appearances- Featured as an expert source in major outlets including the Wall Street Journal
ABC News, Benzinga, and Physical Therapy Products, discussing topics such as gene therapy for Parkinson's treatment …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uab.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
John Hauth, MD
University of Alabama at Birmingham